Bio-Rad Launches The In2it A1C Analyzer For Point-Of-Care Diabetes Testing

Bio-Rad Laboratories, Inc. (AMEX: BIO) and (AMEX: BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced the launch of the in2it? analyzer for the “point-of-care” market. The in2it analyzer measures A1C, a well established indicator of a diabetic patient’s glucose control, and offers healthcare professionals greater efficiency and convenience by providing laboratory-accurate A1C test results — while the patient waits. [click link for full article]

More: continued here

Filed under: Medical Devices on November 18th, 2007